EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Targeted nonviral delivery of genome editors in vivo

Connor A Tsuchida iD, Kevin M Wasko, Jennifer R Hamilton iD, Jennifer A Doudna iD

Proceedings of the National Academy of Sciences · 12.03.2024 · 121 (11)

DOI: 10.1073/pnas.2307796121 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.03.2024. Verfasst von Connor A Tsuchida und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Berkeley-University of California, San Francisco Graduate Program in Bioengineering, University of California, Berkeley, CA…. Hauptthemen laut MEDLINE: Commerce, Gene Editing. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell-type-specific in vivo delivery of genome editing molecules is the next breakthrough that will drive biological discovery and transform the field of cell and gene therapy. Here, we discuss recent advances in the delivery of CRISPR-Cas genome editors either as preassembled ribonucleoproteins or encoded in mRNA. Both strategies avoid pitfalls of viral vector-mediated delivery and offer advantages including transient editor lifetime and potentially streamlined manufacturing capability that are already proving valuable for clinical use. We review current applications and future opportunities of these emerging delivery approaches that could make genome editing more efficacious and accessible in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CommerceGene EditingGenetic TherapyRNA, MessengerRibonucleoproteins

Stichwörter der Autor:innen

CRISPR-Casgenome editingin vivo deliverynonviral deliverytargeted delivery

Substanzen

RNA, MessengerRibonucleoproteins

Autor:innen und Institutionen

  • University of California, Berkeley-University of California, San Francisco Graduate Program in Bioengineering, University of California, Berkeley, CA 94720.
  • Innovative Genomics Institute, University of California, Berkeley, CA 94720.
  • Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
  • Department of Chemistry, University of California, Berkeley, CA 94720.
  • California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720.
  • Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720.

ORCID-Profile: Connor A Tsuchida, Jennifer R Hamilton, Jennifer A Doudna

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NHGRI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Tsuchida, C. A., Wasko, K. M., Hamilton, J. R., & Doudna, J. A. (2024). Targeted nonviral delivery of genome editors in vivo. Proceedings of the National Academy of Sciences, 121(11). https://doi.org/10.1073/pnas.2307796121

Vancouver

Tsuchida CA, Wasko KM, Hamilton JR, Doudna JA. Targeted nonviral delivery of genome editors in vivo. Proceedings of the National Academy of Sciences. 2024;121(11). doi:10.1073/pnas.2307796121

BibTeX
@article{Tsuchida2024,
  author = {Tsuchida, Connor A and Wasko, Kevin M and Hamilton, Jennifer R and Doudna, Jennifer A},
  title = {Targeted nonviral delivery of genome editors in vivo},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {11},
  doi = {10.1073/pnas.2307796121}
}
Kostenlos starten →